Bristol Myers Squibb

Bristol Myers Squibb (BMY) CEO Calls for Fair Global Drug Pricing
Guru Focus
Fri, 05/16/25 - 11:32 am
Bristol Myers Squibb
Pharma CEOs
Chris Boerner
Donald Trump
drug pricing
'Now is not the time to retreat': BMS CEO blasts Trump admin tariffs, health reforms amid $40B US investment pledge
Fierce Pharma
Tue, 05/6/25 - 10:49 am
Bristol Myers Squibb
Chris Boerner
tariffs
Donald Trump
layoffs
Bristol Myers charts 500-plus new layoffs in NJ following expanded cost savings drive
Fierce Pharma
Mon, 05/5/25 - 11:10 pm
Bristol Myers Squibb
layoffs
New Jersey
Will Cobenfy’s clinical stumble derail a once-predicted rise?
Pharma Voice
Tue, 04/29/25 - 08:12 am
Bristol Myers Squibb
Cobenfy
schizophrenia
clinical trials
Bristol Myers says schizophrenia drug launch ‘off to a solid start’
BioPharma Dive
Thu, 04/24/25 - 09:11 pm
Bristol Myers Squibb
schizophrenia
Cobenfy
drug launches
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
CNBC
Thu, 04/24/25 - 11:28 am
Bristol Myers Squibb
earning
tariffs
Cobenfy Falls Short in Phase 3 ARISE Trial as Adjunctive Schizophrenia Therapy
HCP Live
Tue, 04/22/25 - 07:38 pm
Bristol Myers Squibb
Cobenfy
schizophrenia
clinical trials
As Bluesky continues to grow, opportunities abound for pharma brands
Medical Marketing and Media
Wed, 04/16/25 - 11:30 am
social media
pharma marketing
Big Pharma
Bluesky
Novartis
AstraZeneca
Bristol Myers Squibb
Bristol Myers stumbles in bid to widen heart drug’s use
BioPharma Dive
Tue, 04/15/25 - 11:29 am
Bristol Myers Squibb
Camzyos
hypertrophic cardiomyopathy
Bristol Myers combo follows Roche, AstraZeneca immunotherapy rivals into first-line liver cancer
Fierce Pharma
Sun, 04/13/25 - 11:19 pm
Bristol Myers Squibb
Opdivo
Yervoy
hepatocellular carcinoma
FDA
The 5 largest biopharma layoffs of Q1 2025
BioSpace
Fri, 04/11/25 - 11:47 am
layoffs
Novartis
Galapagos
Bristol Myers Squibb
Merck
Gilead Sciences
BMS prevails in antitrust lawsuit over its defense of multiple myeloma blockbuster Pomalyst
Fierce Pharma
Wed, 04/9/25 - 11:45 am
Bristol Myers Squibb
Multiple Myeloma
Pomalyst
legal
antitrust
Five Biggest Drug Face-Offs in Pharma History
BioSpace
Wed, 04/9/25 - 11:38 am
competition
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Pfizer
Bayer
JNJ
Eliquis
Xarelto
Biogen
Eisai
Eli Lilly
Leqembi
Kisunla
AbbVie
Humira
Stelara
AstraZeneca
Calquence
Imbruvica
FDA Approves Opdivo Plus Yervoy For Some With Colorectal Cancer
Cure Today
Tue, 04/8/25 - 10:49 pm
Bristol Myers Squibb
Opdivo
Yervoy
colorectal cancer
FDA
The top 10 pharma R&D budgets for 2024
Fierce Biotech
Fri, 04/4/25 - 11:30 am
R&D
Merck
JNJ
Roche
AstraZeneca
AbbVie
Bristol Myers Squibb
Eli Lilly
Pfizer
Novartis
Sanofi
5 Big Pharmas Push Boundaries in Radiopharmaceuticals
BioSpace
Wed, 04/2/25 - 11:38 am
radiopharmaceuticals
Novartis
Bayer
AstraZeneca
Bristol Myers Squibb
Eli Lilly
2seventy bio, Bluebird’s cell therapy spinout, sells to Bristol Myers for less than $300M
BioPharma Dive
Tue, 03/11/25 - 11:33 am
2seventy bio
Bluebird Bio
Bristol Myers Squibb
cell therapy
M&A
Trial results enhance Bristol Myers' bid for Sotyktu in psoriatic arthritis
Fierce Pharma
Mon, 03/10/25 - 09:33 am
Bristol Myers Squibb
Sotyktu
psoriatic arthritis
clinical trials
What’s driving pharma’s layoffs in 2025
Pharma Voice
Mon, 03/10/25 - 09:27 am
layoffs
CRISPR Therapeutics
Galapagos
Atara Biotherapeutics
Bristol Myers Squibb
Eisai
Biogen
BMS pushes Fulcrum off its list of partners, scrapping MyoKardia heart muscle pact
Fierce Biotech
Wed, 03/5/25 - 11:13 pm
Bristol Myers Squibb
MyoKardia
Fulcrum Therapeutics

Pages